Association of gut microbiota and metabolites with tumor response to immune checkpoint inhibitors in patients with unresectable hepatocellular carcinoma.

被引：5
|
作者：
Lee, Pei-Chang
Wu, Chi-Jung
Hung, Ya-Wen
Lee, Chieh-Ju
Chao, Yee
Hou, Ming-Chih
Kuo, Yu-Lun
Chou, Shih-Hsuan
Huang, Yi-Hsiang
机构：
[1] Taipei Vet Gen Hosp, Div Gastroenterol & Hepatol, Dept Med, Taipei, Taiwan
[2] Taipei Vet Gen Hosp, Div Gastroenterol & Hepatol, Taipei, Taiwan
[3] Taipei Vet Gen Hosp, Taipei, Taiwan
[4] Biotools Co Ltd, New Taipei, Taiwan
[5] Natl Yang Ming Univ, Taipei Vet Gen Hosp, Div Gastroenterol & Hepatol, Inst Clin Med, Taipei, Taiwan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e16165
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16165
引用
收藏
页数：3
相关论文
共 50 条
  • [31] ALTERNATION OF GUT MICROBIOTA IN PATIENT WITH IMMUNE CHECKPOINT INHIBITORS
    Hirata, Yuki
    Tawa, Hideki
    Tanaka, Yasuyoshi
    Kakimoto, Kazuki
    Kawakami, Ken
    Takeuchi, Toshihisa
    Higuchi, Kazuhide
    GASTROENTEROLOGY, 2020, 158 (06) : S1164 - S1165
  • [32] ALTERNATION OF GUT MICROBIOTA IN PATIENT WITH IMMUNE CHECKPOINT INHIBITORS
    Hirata, Yuki
    Kinoshita, Naohiko
    Tawa, Hideki
    Tanaka, Yasuyoshi
    Koshiba, Ryoji
    Kakimoto, Kazuki
    Takeuchi, Toshihisa
    Miyazaki, Takako
    Nakamura, Shiro
    Higuchi, Kazuhide
    GASTROENTEROLOGY, 2021, 160 (06) : S367 - S368
  • [33] Lenvatinib with or without immune checkpoint inhibitors for patients with unresectable hepatocellular carcinoma in real-world clinical practice
    Chen, Kang
    Wei, Wei
    Liu, Lei
    Deng, Zhu-Jian
    Li, Le
    Liang, Xiu-Mei
    Guo, Ping-Ping
    Qi, Lu-Nan
    Zhang, Zhi-Ming
    Gong, Wen-Feng
    Huang, Shan
    Yuan, Wei-Ping
    Ma, Liang
    Xiang, Bang-De
    Li, Le-Qun
    Zhong, Jian-Hong
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (05) : 1063 - 1074
  • [34] Lenvatinib with or without immune checkpoint inhibitors for patients with unresectable hepatocellular carcinoma in real-world clinical practice
    Kang Chen
    Wei Wei
    Lei Liu
    Zhu-Jian Deng
    Le Li
    Xiu-Mei Liang
    Ping-Ping Guo
    Lu-Nan Qi
    Zhi-Ming Zhang
    Wen-Feng Gong
    Shan Huang
    Wei-Ping Yuan
    Liang Ma
    Bang-De Xiang
    Le-Qun Li
    Jian-Hong Zhong
    Cancer Immunology, Immunotherapy, 2022, 71 : 1063 - 1074
  • [35] The Tumor and Host Immune Signature, and the Gut Microbiota as Predictive Biomarkers for Immune Checkpoint Inhibitor Response in Melanoma Patients
    Tomela, Katarzyna
    Pietrzak, Bernadeta
    Schmidt, Marcin
    Mackiewicz, Andrzej
    LIFE-BASEL, 2020, 10 (10): : 1 - 25
  • [36] Early Tumor Marker Response Predicts Treatment Outcomes in Patients with Unresectable Hepatocellular Carcinoma Receiving Combined Lenvatinib, Immune Checkpoint Inhibitors, and Transcatheter Arterial Chemoembolization Therapy
    Luo, Meng-Chao
    Wu, Jia-Yi
    Wu, Jun-Yi
    Lin, Zhong-Tai
    Li, Yi-Nan
    Zeng, Zhen-Xin
    Wei, Shao-Ming
    Yan, Mao-Lin
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2023, 10 : 1827 - 1837
  • [37] Which role for predictors of response to immune checkpoint inhibitors in hepatocellular carcinoma?
    Rizzo, Alessandro
    Cusmai, Antonio
    Gadaleta-Caldarola, Gennaro
    Palmiotti, Gennaro
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 16 (04) : 333 - 339
  • [38] Deep learning of pretreatment multiphase CT images for predicting response to lenvatinib and immune checkpoint inhibitors in unresectable hepatocellular carcinoma
    Liao, Nan-Qing
    Deng, Zhu-Jian
    Wei, Wei
    Lu, Jia-Hui
    Li, Min-Jun
    Ma, Liang
    Chen, Qing-Feng
    Zhong, Jian-Hong
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2024, 24 : 247 - 257
  • [39] Predictors of Response and Survival in Immune Checkpoint Inhibitor-Treated Unresectable Hepatocellular Carcinoma
    Lee, Pei-Chang
    Chao, Yee
    Chen, Ming-Huang
    Lan, Keng-Hsin
    Lee, Chieh-Ju
    Lee, I-Cheng
    Chen, San-Chi
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    CANCERS, 2020, 12 (01)
  • [40] Immune Checkpoint Inhibitors in Combinations for Hepatocellular Carcinoma
    Kalasekar, Sharanya Maanasi
    Garrido-Laguna, Ignacio
    Evason, Kimberley Jane
    HEPATOLOGY, 2021, 73 (06) : 2591 - 2593
12345